Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent

Go back to Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
(NASDAQ: GCTK) Delayed: 0.64 -0.01 (1.54%)
Previous Close $0.65    52 Week High $ 
Open $0.66    52 Week Low $ 
Day High $0.67    P/E N/A 
Day Low $0.63    EPS $ 
Volume 74,253